RecruitingPhase 4NCT06330038

Anesthesia and Non-small Cell Lung Cancer Recurrence

Recurrence Free Survival After Curative Resection of Non-small Cell Lung Cancer Between Inhalational Gas Anesthesia and Propofol-based Total IntraVenous Anesthesia: a Multicenter, Randomized, Clinical Trial


Sponsor

Samsung Medical Center

Enrollment

5,384 participants

Start Date

Aug 5, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

There has been ongoing debate about the relationship between cancer recurrence and anesthetic management. Therefore, the investigators will test the hypothesis that the recurrence free survival (RFS) after curative resection of NSCLC is higher in patient who received total intravenous anesthesia (TIVA) than volatile anesthetics in this multi-center randomized trials.


Eligibility

Min Age: 19 Years

Inclusion Criteria3

  • American Society of Anesthesiologists physical status (ASA) Ⅰ-Ⅲ
  • The Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • Lung resection surgery (segmentectomy, lobectomy, bilobectomy, pneumonectomy; video-assisted, robot-assisted, or open) with curative intent for NSCLC (clinical Tumor, Node, Metastasis (TNM) stage Ⅰ- ⅢA).

Exclusion Criteria12

  • Distant metastasis or malignant tumor in other organs that according to the attending surgeon is not in long-term remission
  • Severe neurologic conditions
  • Severe hepatic disease (Child-Pugh classification C)
  • Renal failure requiring renal replacement therapy
  • History of anesthesia and/or surgery within 1 yr
  • Previous surgery due to lung cancer (except diagnostic biopsies)
  • Contraindications to any study medication (history of allergy, hypersensitivity reaction, or any other contraindication)
  • Planned joint extrapulmonary procedure
  • Surgery under cardiopulmonary bypass or extracorporeal membrane oxygenation
  • Postoperative sedation
  • Pregnancy, or lactation
  • Patient refusal.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPropofol

Propofol will be used for the induction and maintenance of general anesthesia.

DRUGInhaled anesthetics

Inhaled anesthetics will be used for the maintenance of general anesthesia.


Locations(1)

Samsung Medical Center

Seoul, Seoul-teukbyeolsi, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06330038


Related Trials